secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001104659-24-024908
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq notifies Jaguar Health of delisting due to low stock price; hearing available
--------------------------------------------------------------------------------

- Nasdaq determined to delist JAGX effective Feb 26, 2024, as stock closed at $0.10 or less for 10 consecutive trading days.
- Company may request a hearing by Feb 22, 2024, to stay suspension pending Panel decision.
- Previous bid price deficiency notice was given May 2023; extension until May 6, 2024 was in effect.
- No assurance that the Panel will grant an extension if hearing is requested.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000110465924024908/0001104659-24-024908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000110465924024908/tm246476d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-024908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer